The maternal clinical condition, the presence of underlying heart disease, laboratory tests including 12 lead ECG, echocardiography, hs-cTnT, electronic fetal monitoring, gestational age, and physician's choice generally affect the mode of treatment (Flow Diagram 1: Management of atrial fibrillation in a pregnant female). The gene discussed is TNNT2; the disease is heart disorder.